Literature DB >> 26546825

Inhibition of osteoclast differentiation by overexpression of NDRG2 in monocytes.

Kyeongah Kang1, Sorim Nam1, Bomi Kim1, Ji Hyun Lim1, Young Yang1, Myeong-Sok Lee1, Jong-Seok Lim2.   

Abstract

N-Myc downstream-regulated gene 2 (NDRG2), a member of the NDRG family of differentiation-related genes, has been characterized as a regulator of dendritic cell differentiation from monocytes, CD34(+) progenitor cells, and myelomonocytic leukemic cells. In this study, we show that NDRG2 overexpression inhibits the differentiation of U937 cells into osteoclasts in response to stimulation with a combination of macrophage colony-stimulating factor (M-CSF) and soluble receptor activator of NF-κB ligand (RANKL). U937 cells stably expressing NDRG2 are unable to differentiate into multinucleated osteoclast-like cells and display reduced tartrate-resistant acid phosphatase (TRAP) activity and resorption pit formation. Furthermore, NDRG2 expression significantly suppresses the expression of genes that are crucial for the proliferation, survival, differentiation, and function of osteoclasts, including c-Fos, Atp6v0d2, RANK, and OSCAR. The activation of ERK1/2 and p38 is also inhibited by NDRG2 expression during osteoclastogenesis, and the inhibition of osteoclastogenesis by NDRG2 correlates with the down-regulation of the expression of the transcription factor PU.1. Taken together, our results suggest that the expression of NDRG2 potentially inhibits osteoclast differentiation and plays a role in modulating the signal transduction pathway responsible for osteoclastogenesis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NDRG2; Osteoclastic cytokines; Osteoclastogenesis; U937 cells

Mesh:

Substances:

Year:  2015        PMID: 26546825     DOI: 10.1016/j.bbrc.2015.10.167

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  EZH2 regulates the balance between osteoclast and osteoblast differentiation to inhibit arthritis-induced bone destruction.

Authors:  Fang Cheng; Huimin Li; Jing Liu; Fengfeng Yan; Yu Chen; Haiyan Hu
Journal:  Genes Immun       Date:  2022-05-17       Impact factor: 2.676

2.  Small RNAs detected in exosomes derived from the MH7A synovial fibroblast cell line with TNF-α stimulation.

Authors:  Yosuke Takamura; Wataru Aoki; Atsushi Satomura; Seiji Shibasaki; Mitsuyoshi Ueda
Journal:  PLoS One       Date:  2018-08-10       Impact factor: 3.240

3.  NELFE promoted pancreatic cancer metastasis and the epithelial‑to‑mesenchymal transition by decreasing the stabilization of NDRG2 mRNA.

Authors:  Lili Han; Ying Zan; Chen Huang; Shuqun Zhang
Journal:  Int J Oncol       Date:  2019-10-02       Impact factor: 5.650

4.  N-myc Downstream-Regulated Gene 2 (NDRG2) Promotes Bone Morphogenetic Protein 2 (BMP2)-Induced Osteoblastic Differentiation and Calcification by Janus Kinase 3 (JAK3)/Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway.

Authors:  SunYu Chen; JianKun Wang; Chao Cai; Xiaoyan Xie
Journal:  Med Sci Monit       Date:  2020-01-08

5.  Expression Profile of Osteoclasts Following the Stimulation With Interleukin-23 in Mice.

Authors:  Miao Chen; Dan-Dan Pang; Sheng-Ming Dai
Journal:  Arch Rheumatol       Date:  2020-04-27       Impact factor: 1.472

6.  CD13 is a critical regulator of cell-cell fusion in osteoclastogenesis.

Authors:  Mallika Ghosh; Tomislav Kelava; Ivana Vrhovac Madunic; Ivo Kalajzic; Linda H Shapiro
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.996

7.  NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis.

Authors:  Liangliang Shen; Xuan Qu; Huichen Li; Chunsheng Xu; Mengying Wei; Qinhao Wang; Yi Ru; Bei Liu; Yuqiao Xu; Kai Li; Junbi Hu; Lifeng Wang; Yongzheng Ma; Mengyang Li; Xiaofeng Lai; Lei Gao; Kaichun Wu; Libo Yao; Jianyong Zheng; Jian Zhang
Journal:  Oncogene       Date:  2018-01-18       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.